Expert consultation and tailored strategies help biotech and medical device companies navigate Middle East regulatory complexities, fast-tracking approvals in Saudi Arabia, UAE, Egypt, and ensuring compliance with ISO 13485, GxP, and vigilance reporting.
Best practices for medical device lifecycle management in the Middle East and GCC include understanding country-specific regulations, implementing ISO 13485 QMS, ensuring Arabic labeling, post-market vigilance, and securing licensed distributors for smooth market access.
Effective GCC medical device lifecycle management requires strict compliance with SFDA and MOHAP regulations, including registration, Arabic labeling, Saudi UDI, post-market surveillance, license renewal, and recall management.
Effective Lifecycle Management for Medical Devices in GCC Markets Read More »
